Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene—a gene that can cause cancer—that may ...

In a world first, scientists have created mice with two fathers, capable of having offspring of their own. It’s a huge step ...

Using gene editing in a preclinical model, researchers at UT Southwestern Medical Center blocked the symptoms of a rare smooth muscle disease before they developed. Their findings, published in ...

Zebrafish have the remarkable and rare ability to regrow and repair their hearts after damage. New research from Caltech and ...

To carry out the experiment, researchers used sperm from two different strains of mice. One strain was bred in European labs; ...

The projected fair value for CRISPR Therapeutics is US$83.24 based on 2 Stage Free Cash Flow to Equity CRISPR Therapeutics' US$45.55 share price signals that it might be 45% undervalued The analyst ...

This might help: The analyst community's current consensus price target of $77.21 is about 75% above this stock's present price. Finally, add Confluent ( CFLT -0.13%) to your list of the best stocks ...

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...